Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing

Wound Repair and Regeneration

Volumn 12, Issue 3, 2004, Pages 295-304

  Gillard, Judith A ^a   Reed, Malcolm W R ^a   Buttle, David ^a   Cross, Simon S ^a   Brown, Nicola J ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; EPITHELIZATION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SCAR FORMATION; SKIN INJURY; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; CICATRIX; DERMIS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MASTECTOMY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; WOUND HEALING;

EID: 3042811911     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.012314.x     Document Type: Article

References (27)

1. Gailit J, Clark RA. Wound repair in the context of extracellular matrix. Current Opin Cell Biol 1994;6:717-25.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
3. Parks WC. Matrix metalloproteinases in repair. Wound Rep Reg 1999;7:423-32.
4. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4.
5. Murphy G. Matrix metalloproteinases and their inhibitors. Acta Orthop Scand Suppl 1995;266:55-60.
6. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J, Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996;135:52-9.
7. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266:13064-9.
8. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-4.
9. Agren MS, Taplin CJ, Woessner JF Jr, Eaglestein WH, Mertz PM. Collagenase in wound healing: effect of wound age and type. J Invest Dermatol 1992;99:709-14.
10. Agren MS. Gelatinase activity during wound healing. Br J Dermatol 1994;131:634-40.
11. Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000;105:638-47. Erratum: Plast Reconstr Surg 2000;106:236-7.
12. Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K. Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg 2000;105:638-47. Erratum: Plast Reconstr Surg 2000;106:236-7.
13. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 1995;104:236-40.
14. Wysocki AB, Kusakabe AO, Chang S, Tuan TL. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Rep Reg 1999;7:154-65.
15. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dernatol 1993;101:64-8.
16. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Reg 1999;7:442-52.
17. Marastschijski U, Impola U, Jahkola T, Karlsmark T, Agren MS, Saarialho-Kere U. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Human Pathol 2002;33:355-64.
18. Knight CG, Willenbrock F, Murphy G. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296:263-6.
19. Rawlings ND, Barrett AJ, FLUSYS. a software package for the collection and analysis of kinetic and scanning data from Perkin-Elmer fluorimeters. Comput Appl Biosci 1990;6:118-9.
20. Singer AJ, Clark RA. Mechanisms of disease: cutaneous wound healing. N Eng J Med 1999;341:738-46.
21. Martin P. Wound healing-aiming for perfect skin regeneration. Science 1997;276:75-81.
22. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
23. Brown NJ, Smyth EA, Cross SS, Reed MWR. Angiogenesis induction and regression in human surgical wounds. Wound Rep Reg 2002;10:245-51.
24. Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP) -1 and -2 proteins and mRNA. J Pathol 1997;183:169-76.
25. Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1-, -2, -3, and -4) in normal and aberrant wound healing. Human Pathol 1999;30:795-802.
26. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr. TIMP-3 binds to sulphated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000;275:31226-32.
27. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994;269:9352-60.